Latest News

22.04.2025

Resolutions at Getinge’s Annual General Meeting April 22, 2025

Getinge AB (publ)’s Annual General Meeting (“AGM”) was held on April 22, 2025 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the following was resolved.

Нормативные документы

22.04.2025
Resolutions at Getinge’s Annual General Meeting April 22, 2025

Getinge AB (publ)’s Annual General Meeting (“AGM”) was held on April 22, 2025 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the following was resolved.

22.04.2025

Getinge Interim Report January-March 2025: Strong sales and improved earnings – continued focus on customer value and profitability going forward

“We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 6.2% while the order intake rose by 2.9% organically.

Нормативные документы

22.04.2025
Getinge Interim Report January-March 2025: Strong sales and improved earnings – continued focus on customer value and profitability going forward

“We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 6.2% while the order intake rose by 2.9% organically.

08.04.2025

Getinge invites fund managers, analysts, and media to Q1 Report 2025 conference call

Getinge will issue its Q1 Report 2025 on April 22, 2025, at 12.00 p.m. CEST, followed by a conference call at 13:00 p.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

Пресс-релиз

08.04.2025
Getinge invites fund managers, analysts, and media to Q1 Report 2025 conference call

Getinge will issue its Q1 Report 2025 on April 22, 2025, at 12.00 p.m. CEST, followed by a conference call at 13:00 p.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

27.03.2025

Getinge publishes Annual Report for 2024

Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, increased customer satisfaction, and successful product launches. The global medtech company has reached new sales records, strengthened its acquisitions, and continued to develop innovative solutions that improve healthcare – all while maintaining a strong focus on quality improvements and adapting to increasing market demands.

Нормативные документы

27.03.2025
Getinge publishes Annual Report for 2024

Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, increased customer satisfaction, and successful product launches. The global medtech company has reached new sales records, strengthened its acquisitions, and continued to develop innovative solutions that improve healthcare – all while maintaining a strong focus on quality improvements and adapting to increasing market demands.

20.03.2025

Embracing Getinge’s purpose

Meet Alisa Stafford, an Office Administrator at Getinge who recently took on a new challenge by stepping in front of the camera to represent the company’s purpose to make life-saving technology accessible to more people.

Пресс-релиз

20.03.2025
Embracing Getinge’s purpose

Meet Alisa Stafford, an Office Administrator at Getinge who recently took on a new challenge by stepping in front of the camera to represent the company’s purpose to make life-saving technology accessible to more people.

18.03.2025

Getinge introduces Neural Pressure Support for the Servo-u ventilator system

Getinge announces the launch of its latest innovation in ICU ventilation – Neural Pressure Support (NPS) – available for both invasive and non-invasive ventilation. Building on its most personalized ventilation modes, NAVA and NIV NAVA, these two new NPS modes offer clinicians more options to provide personalized ventilation that aims to protect both the lungs and diaphragm.

Пресс-релиз

18.03.2025
Getinge introduces Neural Pressure Support for the Servo-u ventilator system

Getinge announces the launch of its latest innovation in ICU ventilation – Neural Pressure Support (NPS) – available for both invasive and non-invasive ventilation. Building on its most personalized ventilation modes, NAVA and NIV NAVA, these two new NPS modes offer clinicians more options to provide personalized ventilation that aims to protect both the lungs and diaphragm.

Company Newsroom

Подпишитесь на нашу новостную ленту

Вопрос?

Resolutions at Getinge’s Annual General Meeting April 22, 2025

22.04.2025
Resolutions at Getinge’s Annual General Meeting April 22, 2025

Getinge Interim Report January-March 2025: Strong sales and improved earnings – continued focus on customer value and profitability going forward

22.04.2025
Getinge Interim Report January-March 2025: Strong sales and improved earnings – continued focus on customer value and profitability going forward

Getinge invites fund managers, analysts, and media to Q1 Report 2025 conference call